CeLLogix™ is a viable allogeneic bone scaffold derived from bone marrow, in full compliance with FDA guidelines regarding human cells, tissues and cellular tissue-based products, and is intended for use in bone remodeling.
The bone scaffold is comprised of a proprietary blend of microparticulate cortical, cancellous and demineralized cortical allograft bone in optimum particle sizes ranging from 100-300 microns. Furthermore, CeLLogix processing preserves a cell population that includes marrow-isolated adult multilineage-inducible (MIAMI) cells. These primitive cells provide properties that in combination with the osteoconductive, osteoinductive, and osteogenic elements of the graft, enhance the patient’s innate healing process.
CeLLogix™ provides the three key elements for bone repair: